Cargando…

Biological therapy of traditional therapy-resistant adult-onset Still’s disease: an evidence-based review

BACKGROUND: Biotherapy is becoming increasingly important in the treatment of adult-onset Still’s disease (AOSD). The aim of our study was to evaluate the efficacy and safety of biological therapy for AOSD resistant to traditional therapy. PATIENTS AND METHODS: Database of Library of Congress, the P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Sha, Qiao, Jianjun, Bai, Juan, Wu, Yinhua, Fang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790106/ https://www.ncbi.nlm.nih.gov/pubmed/29416343 http://dx.doi.org/10.2147/TCRM.S155488

Ejemplares similares

Progress in Biological Therapies for Adult-Onset Still’s Disease
por: Galozzi, Paola, et al.
Publicado: (2022)

Current and emerging biological therapy in adult-onset Still’s disease
por: Ma, Yuning, et al.
Publicado: (2021)

Clinical characteristics and outcome of elderly onset adult-onset Still's disease: A 10-year retrospective study
por: Li, Sheng, et al.
Publicado: (2023)

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies
por: Mavragani, Clio P., et al.
Publicado: (2012)

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease
por: Galozzi, Paola, et al.
Publicado: (2018)

Development and validation of the AF score for diagnosis of adult-onset Still's disease in fever of unknown origin()
por: Ying, Shuni, et al.
Publicado: (2022)

Effectiveness of Dupilumab for an Elderly Patient with Prurigo Nodularis Who Was Refractory and Contradicted to Traditional Therapy
por: Liu, Taoming, et al.
Publicado: (2021)

Adult-Onset Still’s Disease
por: Mitrovic, Stéphane, et al.
Publicado: (2019)

Adult-Onset Still’s Disease
por: Efthimiou, Petros, et al.
Publicado: (2018)

Multiple Eruptive Clear Cell Acanthoma
por: Zhou, Sha, et al.
Publicado: (2018)

Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
por: Kacar, Mark, et al.
Publicado: (2020)

Biological treatment in resistant adult-onset Still’s disease: A single-center, retrospective cohort study
por: Çolak, Seda, et al.
Publicado: (2021)

Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease
por: Brachat, A, et al.
Publicado: (2015)

Adult-onset Still’s disease: Switch to atypical skin manifestations under anakinra therapy
por: Klapproth, Henning, et al.
Publicado: (2023)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Adult Onset Still's Disease and Autoinflammation
por: Efthimiou, Petros, et al.
Publicado: (2012)

Myocarditis in Adult-Onset Still Disease
por: Gerfaud-Valentin, Mathieu, et al.
Publicado: (2014)

Refractory Adult Onset Still’s Disease
por: Sulaiman, Wahinuddin, et al.
Publicado: (2017)

Elderly-onset adult Still’s disease
por: Mzabi, Anis, et al.
Publicado: (2021)

Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease
por: Tsurukawa, Shinichiro, et al.
Publicado: (2016)

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
por: Ichikawa, Takanori, et al.
Publicado: (2019)

Systemic lupus erythematosus in a patient with Turner syndrome
por: Bai, Juan, et al.
Publicado: (2015)

Concurrence of Sweet's Syndrome, Pathergy Phenomenon and Erythema Nodosum-like Lesions()
por: Qiao, Jianjun, et al.
Publicado: (2015)

Biologic therapy for psoriasis - still searching for the best target()
por: Pinto-Almeida, Teresa, et al.
Publicado: (2014)

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
por: Vercruysse, François, et al.
Publicado: (2019)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still’s disease
por: Kondo, Fumiaki, et al.
Publicado: (2022)

Adult onset Still's disease: Role of scintigraphy
por: Nilegaonkar, Sujit, et al.
Publicado: (2012)

Adult onset Still’s disease with dermatopathic lymphadenopathy
por: Qureshi, Ahmad Z., et al.
Publicado: (2016)

Delay in the Diagnosis of Adult-Onset Still’s Disease
por: Pak, Stella, et al.
Publicado: (2017)

Flagellate Rash in Adult-onset Still's Disease
por: Patidar, Abhilasha, et al.
Publicado: (2020)

Atypical Presentation of Adult-Onset Still’s Disease
por: Sobhrakhshankhah, Elham, et al.
Publicado: (2023)

Pulmonary Onset of Adult Onset Still's Disease Complicated with Kikuchi Lymphadenitis
por: Kodithuwakku, G. D. E., et al.
Publicado: (2020)

Clinical characteristics and treatment of elderly onset adult-onset Still’s disease
por: Kishida, Dai, et al.
Publicado: (2022)

Update on the therapy of adult-onset Still’s disease with a focus on IL-1-inhibition: a systematic review
por: Kedor, Claudia, et al.
Publicado: (2021)

About the complexity of adult onset Still’s disease… and advances still required for its management
por: Guilpain, Philippe, et al.
Publicado: (2017)

The role of platelet to mean platelet volume ratio in the identification of adult-onset still’s disease from sepsis
por: Ge, Suohua, et al.
Publicado: (2021)

Adult-onset Still's disease with vesiculopustules on the hands and feet.
por: Lee, Jee Bum, et al.
Publicado: (2002)

Adult-onset Still's disease associated with collapsing glomerulopathy
por: Arulkumaran, Nishkantha, et al.
Publicado: (2010)

Atypical Cutaneous Manifestations in Adult Onset Still's Disease
por: Nataraja, Champa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2bf7pdb9u7p0kfs12a8f0caal8